
Journal of labelled compounds and radiopharmaceuticals p. 385 - 394 (2000)
Update date:2022-07-30
Topics:
Katsifis, Andrew
Mattner, Filomena
Zhang, Zhianko
Dikic, Branko
Papazian, Vahan
The [123I] labelled imidazo[1,2-a]pyridine [123I]iodozolpidem 4 was found to exhibit preferential activity towards Peripheral rather than Central Benzodiazepine receptors in vivo and was synthesised for the potential study of the Peripheral Benzodiazepine Receptors (PBR) using SPECT. [123I]Iodozolpidem was prepared from the corresponding tributyl tin precursor by iododestannylation with Na[123I] in the presence of peracetic acid or chloramine-T. Purification by semipreparative C-18 RP HPLC gave the product in radiochemical yields of 60-85%. The product was obtained in > 97% chemical and radiochemical puritiy with a specific activity > 80 GBq/μmol.
View MoreNanjing Habo Medical Technology Co., Ltd.
Contact:025-85769882
Address:No.108. Ganjiabian east. Qixia District .Nanjing
HANGZHOU FOREWIN PHARMA CO., LTD
Contact:+86-571-89053961
Address:hangzhou
JIANGSU GRAND XINYI PHARMACEUTICAL CO.,LTD
website:http://www.xypharm.com/
Contact:+86-515-84383317
Address:Chenli Road,Costal Chemical Area Binhai,Yancheng, Jiangsu,China
Contact:0086 533 2282832
Address:Zibo,Shandong
Shanghai doly chemical Co.,Ltd
Contact:+86-21-34716221
Address:No.328,WuHe Roard,MinHang,ShangHai China
Doi:10.1021/jm00298a049
(1970)Doi:10.1021/ol025760o
(2002)Doi:10.1016/S0040-4020(00)00193-9
(2000)Doi:10.1021/acs.joc.6b01286
(2016)Doi:10.1016/S0040-0(02)01564-8
(2003)Doi:10.1063/1.1286418
(1943)